The type dimension of the Wound‑cleaning Potion market is divided into four principal sub‑categories: antiseptic, enzymatic, herbal and synthetic polymer‑based formulations. Antiseptic potions, typically containing iodine or chlorhexidine, dominate the market due to their broad‑spectrum efficacy and regulatory endorsement, accounting for roughly one‑third of total sales. Enzymatic variants, which leverage proteolytic activity to debride necrotic tissue, capture a growing niche among advanced care facilities, contributing about 22 % of revenue. Herbal potions, derived from plant extracts such as neem or tea tree oil, appeal to consumers seeking natural alternatives and represent approximately 18 % of the market. Synthetic polymer‑based solutions, engineered for controlled release of active agents, are emerging in high‑tech wound‑care settings and currently hold close to 15 % of sales. The remaining 10 % consists of hybrid products that blend two or more of these technologies. Together, these type segments define the overall market size and shape strategic investment decisions across the Wound‑cleaning Potion taxonomy.